Literature DB >> 6284595

Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables.

M Hendrickson, J Ross, P J Eifel, R S Cox, A Martinez, R Kempson.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 6284595     DOI： 10.1016/0090-8258(82)90076-2

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  11 in total

1.  Radiotherapy: Intermediate-risk endometrial cancer--adjuvant treatment.

Authors:  Patricia J Eifel
Journal:  Nat Rev Clin Oncol       Date:  2010-10       Impact factor: 66.675

2.  Diagnostic Performance of Computed Tomography for Preoperative Staging of Patients with Non-endometrioid Carcinomas of the Uterine Corpus.

Authors:  Yulia Lakhman; Seth S Katz; Debra A Goldman; Derya Yakar; Hebert A Vargas; Ramon E Sosa; Maura Miccò; Robert A Soslow; Hedvig Hricak; Nadeem R Abu-Rustum; Evis Sala
Journal:  Ann Surg Oncol       Date:  2015-02-10       Impact factor: 5.344

3.  Factors prognostic of survival in advanced-stage uterine serous carcinoma.

Authors:  Laura L Holman; Navdeep Pal; David A Iglesias; Pamela T Soliman; Nyla Balakrishnan; Ann Klopp; Russell R Broaddus; Nicole D Fleming; Mark F Munsell; Karen H Lu; Shannon N Westin
Journal:  Gynecol Oncol       Date:  2017-04-30       Impact factor: 5.482

4.  Preoperative CT-based nomogram for predicting overall survival in women with non-endometrioid carcinomas of the uterine corpus.

Authors:  Yulia Lakhman; Derya Yakar; Debra A Goldman; Seth S Katz; Hebert A Vargas; Maura Miccò; Junting Zheng; Chaya S Moskowitz; Robert A Soslow; Hedvig Hricak; Nadeem R Abu-Rustum; Evis Sala
Journal:  Abdom Imaging       Date:  2015-08

5.  Insights into endometrial serous carcinogenesis and progression.

Authors:  Oluwole Fadare; Wenxin Zheng
Journal:  Int J Clin Exp Pathol       Date:  2009-01-10

6.  Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis.

Authors:  Amanda N Fader; Dana M Roque; Eric Siegel; Natalia Buza; Pei Hui; Osama Abdelghany; Setsuko Chambers; Angeles Alvarez Secord; Laura Havrilesky; David M O'Malley; Floor J Backes; Nicole Nevadunsky; Babak Edraki; Dirk Pikaart; William Lowery; Karim ElSahwi; Paul Celano; Stefania Bellone; Masoud Azodi; Babak Litkouhi; Elena Ratner; Dan-Arin Silasi; Peter E Schwartz; Alessandro D Santin
Journal:  Clin Cancer Res       Date:  2020-06-29       Impact factor: 12.531

7.  Management of women with surgically staged 1 uterine papillary serous cancer.

Authors:  Laurie Elit; Andre Laroche; Lauren Smith; John Mazurka; Francois Moens; Jan Hauspy; Waldo Jimenez
Journal:  ISRN Obstet Gynecol       Date:  2011-09-11

8.  The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer.

Authors:  Wan Kyu Eo; Sanghoon Kwon; Suk Bong Koh; Min Jeong Kim; Yong Il Ji; Ji Young Lee; Dong Soo Suh; Ki Hyung Kim; Heung Yeol Kim
Journal:  J Cancer       Date:  2016-02-20       Impact factor: 4.207

9.  Multiple brain metastases in a patient with uterine papillary serous adenocarcinoma: Treatment options for this rarely seen metastatic brain tumor.

Authors:  Salih Gulsen; Aysen Terzi
Journal:  Surg Neurol Int       Date:  2013-08-28

10.  MUC1 stimulates EGFR expression and function in endometrial cancer.

Authors:  Brian J Engel; Jessica L Bowser; Russell R Broaddus; Daniel D Carson
Journal:  Oncotarget       Date:  2016-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.